Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Syros Presents Data from Phase 1/1b Clinical Trial of SY-5609 in Advanced Solid Tumors at ASCO Annual Meeting
Syros Pharmaceuticals, a biopharmaceutical company committed to advancing new standards of care for the frontline […]
Vigeo Therapeutics New Immune Profiling and Biomarker Data Ph I/II Expansion Study in GBM Patients
Vigeo Therapeutics, a clinical-stage immuno-oncology company pioneering novel cancer therapies, has announced encouraging new data […]
Takeda and HUTCHMED Announce New Drug Application (NDA) for Fruquintinib for Treatment of Previously Treated Metastatic Colorectal Cancer Granted Priority Review
Takeda and HUTCHMED have announced that the U.S. Food and Drug Administration (“FDA”) has granted […]
CHA Medical & Bio Group Expands Its Global Presence With Launch of Anti-Aging Research Institute in Los Angeles
CHA Medical & Bio Group, a global leader in stem cell research based in South […]
Genome Medical Supporting Beam Therapeutics on its Sickle Cell Disease Clinical Trial
Genome Medical, the leading telehealth provider of genetic services and solutions, is teaming up with […]
HanAll Biopharma and Daewoong Pharmaceutical Enter into Co-Development Agreement with NurrOn Pharmaceuticals to Develop Therapy for Parkinson's Disease
HanAll Biopharma and Daewoong Pharmaceutical announced that they have entered into a co-development agreement with NurrOn […]
ClearPoint Neuro and UCB Enter License Agreement for Gene Therapy Drug Delivery
ClearPoint Neuro, a global therapy-enabling platform company providing navigation and delivery to the brain, today […]
Lynk Pharmaceuticals Announces First Cohort of Psoriatic Patients Dosed with LNK01004
Lynk Pharmaceuticals, an innovative clinical stage company, announced that it has dosed the first cohort […]
TriLink BioTechnologies® Announces Manufacturing Capabilities Expansion as mRNA Manufacturing Facility Nears Completion
TriLink BioTechnologies, a Maravai LifeSciences company and global provider of life science reagents and services, […]
Topas Therapeutics Initiates Phase 2a Clinical Trial for TPM502 in Celiac Disease; Appoints Chief Business Officer and Chief Operating Officer
Topas Therapeutics, a clinical-stage biotech company developing novel antigen-specific immune tolerance therapies to treat autoimmune […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more